JS-201

N/A

Report date: 2024/03/21 12:54:08

Base Information

Drug NameJS-201
Drug Alias NameJS-201
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTransforming growth factor beta inhibitorsProgrammed cell death protein 1 blockers
TargetsTransforming growth factor betaProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Junshi Biosciences Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Junshi Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A